Fundraising FoxTopspin Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Codagenixcodagenix.comin𝕏Feb 2023 · $20M
Codagenix develops viral vaccines and virotherapeutics using codon deoptimization, a method for engineering attenuated viruses.
BiotechDeep TechHealthtechFarmingdale, US
John Robert Coleman(Executive Officer, Director)Steffen Mueller(Co-Founder, President & Chief Scientific Officer)inCharlie Petty(Director)Steven Winick(Director)Jill Howe(Director)Paul Grint(Executive Chairman & Interim CEO)in
Co-investorsAdjuvant CapitalIn-Q-Tel
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.